GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32376799.
- Also identified by DOI 10.1172/jci.insight.128820 and PMC identifier 7253016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
EIF2AK4, which encodes the amino acid deficiency-sensing protein GCN2, has been implicated as a susceptibility gene for type 2 diabetes in the Japanese population. However, the mechanism by which GCN2 affects glucose homeostasis is unclear. Here, we show that insulin secretion is reduced in individuals harboring the risk allele of EIF2AK4 and that maintenance of GCN2-deficient mice on a high-fat diet results in a loss of pancreatic β cell mass. Our data suggest that GCN2 senses amino acid deficiency in β cells and limits signaling by mechanistic target of rapamycin complex 1 to prevent β cell failure during the consumption of a high-fat diet.
Medical subject headings
- Amino Acids
- Diabetes Mellitus, Type 2
- Insulin-Secreting Cells
- Liver
- Protein Serine-Threonine Kinases